Loading clinical trials...
Loading clinical trials...
Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Conditions
Interventions
Documentation
Locations
2
Germany
Uniklinik Essen
Essen, North Rhine-Westphalia, Germany
Uniklinik Münster
Münster, North Rhine-Westphalia, Germany
Start Date
March 8, 2019
Primary Completion Date
February 28, 2021
Completion Date
February 28, 2021
Last Updated
December 23, 2022
Lead Sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions